Related Experiment Video
Updated: Jul 29, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Practical use of retinoids in psoriasis
1Roche International Clinical Research Center, Strasbourg, France.
Retinoids have transformed dermatology, effectively treating severe acne and pustular psoriasis. Careful use, including combination therapies, offers powerful options for persistent skin conditions.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Retinoids have significantly advanced dermatologic treatments over the past two decades.
- Isotretinoin and etretinate have shown dramatic efficacy in severe acne and pustular psoriasis, respectively.
Purpose of the Study:
- To review the utility, safety, and cost-effectiveness of retinoids in dermatologic practice.
- To highlight the benefits of retinoids, including combination therapies, for recalcitrant skin conditions.
Main Methods:
- Review of clinical outcomes with retinoid therapy, including isotretinoin and etretinate.
- Evaluation of combination therapy with UV light (retinoid-light combinations).
- Consideration of retinoid safety profiles, particularly regarding pregnancy prevention.
Main Results:
- Retinoids offer effective treatment for severe acne and pustular psoriasis.
- Combination therapy allows for reduced retinoid and UV light dosage with improved response.
- Retinoids are generally safe and cost-effective therapeutic options.
Conclusions:
- Retinoids are a powerful therapeutic option for severe and recalcitrant dermatologic conditions.
- Careful patient management, especially concerning pregnancy prevention, is crucial for safe retinoid use.
- Ongoing molecular biology research suggests a promising future for retinoid-based therapies in dermatology.
More Related Videos
05:03Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
08:18Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein
Published on: October 4, 2024